ADC Linker

N3-C3-NHS ester is a non-cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound features an azide functionality, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAC) with alkyne-containing molecules. Additionally, it can engage in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN-modified entities. N3-C3-NHS ester is a valuable tool for enhancing the specificity and efficacy of ADCs in targeted cancer therapies.

MethylCBI-azaindole-benzamide-MOM-Boc-ethylenediamine-D is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This compound facilitates the targeted delivery of cytotoxic agents to specific tumor cells, enhancing therapeutic efficacy while minimizing systemic toxicity. Its application is vital in the development of ADCs for cancer research and potential therapeutic interventions.

DBCO-PEG4-DBCO is a PEG-based linker primarily designed for use in antibody-drug conjugates (ADCs) and PROTAC synthesis. This compound features a dibenzocyclooctyne (DBCO) group, facilitating strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. Its versatile reactivity enables the development of targeted therapeutics, enhancing specificity and efficacy in research applications focused on protein degradation and targeted delivery systems.

Dibromomaleimide-C5-COOH is a bifunctional dibromomaleimide linker designed for Antibody-Drug Conjugates (ADCs). This compound facilitates the conjugation of drugs such as MMAF, enabling the targeted delivery of cytotoxic agents to cancer cells. Its application in ADC synthesis supports advancements in targeted cancer therapeutics and research into novel drug delivery systems.

MC-Gly-Gly-Phe-Gly-PAB-PNP is a chemically engineered linker specifically designed for the synthesis of antibody-drug conjugates (ADCs) targeting human epidermal growth factor receptor (EGFR). This compound facilitates the stable attachment of therapeutic agents to antibodies, enhancing selective delivery to tumor cells while minimizing off-target effects. Its structural properties contribute to improved pharmacokinetics and therapeutic efficacy in cancer research applications.

6-O-Propynyl-2'-deoxyguanosine is an alkyne-containing reagent utilized in click chemistry applications. This compound serves as a valuable tool for investigating biochemical pathways and interactions involving nucleic acids. Its unique structure enables researchers to explore DNA modifications and conjugation strategies, facilitating advancements in molecular biology and bioconjugation studies.

TCO-PEG3-maleimide is a click chemistry reagent that facilitates the efficient conjugation of trans-cyclooctene (TCO) moieties to thiol-containing molecules, including antibodies and cysteine-containing peptides. Through a rapid and selective reaction with thiol groups, this compound is valuable for a variety of bioconjugation applications. Its unique properties enable researchers to explore novel therapeutic strategies and enhance the development of bioconjugates in chemical biology.

PDEC-NB is a disulfide cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This compound facilitates the targeted delivery of cytotoxic agents to cancer cells, enhancing therapeutic efficacy while minimizing off-target effects. Its ability to undergo selective cleavage in reducing environments makes it a valuable tool for researchers developing ADCs in cancer therapy.

Fmoc-Val-Ala-PAB-OH is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). It facilitates the conjugation of drugs to antibodies, enabling targeted delivery for enhanced therapeutic efficacy. This compound is critical in the development of ADCs for various cancer treatments and biomedical research applications.

Mal-amido-PEG2-NHS ester is an ADC linker featuring a maleimide group and an NHS ester. This compound enables the conjugation to primary amines (-NH2) present in proteins, amine-modified oligonucleotides, and various amine-containing molecules. Its non-cleavable nature makes it particularly suitable for applications in antibody-drug conjugates (ADCs), enhancing stability and efficacy in therapeutic research.

m-PEG2-Amine is a polyethylene glycol (PEG)-based linker designed for use in PROTAC (Proteolysis Targeting Chimeras) synthesis and antibody-drug conjugate (ADC) development. This cleavable linker facilitates the integration of therapeutic agents with antibodies, enhancing cellular uptake and stability. m-PEG2-Amine is essential for researchers focusing on targeted protein degradation and ADC formulations in therapeutic development.

Fmoc-NH-PEG4-CH2COOH is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs) and PROTACs. This PEG-based compound facilitates the development of targeted protein degradation strategies by enabling the construction of functional PROTACs. Its structural attributes support precise conjugation while maintaining stability in various biological environments, making it suitable for innovative therapeutic applications in chemical biology research.

DBCO-PEG3-oxyamine is a non-cleavable linker specifically designed for antibody-drug conjugate (ADC) synthesis. Featuring a DBCO moiety, this reagent facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with azide-containing molecules. Its application in conjugating antibodies to therapeutic agents enhances targeted delivery and efficacy in cancer research and drug development.

18-Azido-stearic acid serves as a versatile click chemistry reagent characterized by its azide functional group. It acts as a hydrophobic bioconjugation linker and can be modified at the azido-position via copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it is suitable for ring strain-promoted alkyne-azide cycloaddition (SPAAC) when reacted with DBCO or BCN derivatives. This compound is particularly useful in the fields of bioconjugation and chemical biology for the development of complex biomolecular assemblies.

Bis-PEG4-NHS ester serves as an amine-reactive crosslinking reagent that targets primary amine groups on liposome surfaces, facilitating the formation of covalent amide bonds. The hydrophilic PEG4 spacer minimizes steric hindrance, allowing for efficient site-specific antibody coupling via copper-free strain-promoted azide-alkyne cycloaddition without compromising liposome integrity. Additionally, Bis-PEG4-NHS ester hydrolyzes during annealing to generate -COOH groups, which enhance perovskite structural integrity, passivate defects, and refine nucleation kinetics, ultimately improving crystal growth. This compound is also beneficial as an antisolvent additive in p−i−n perovskite solar cells, contributing to enhanced device efficiency and long-term stability.

Bis-PEG6-NHS ester is a polyethylene glycol (PEG)-based PROTAC linker that facilitates the synthesis of proteolysis-targeting chimeras (PROTACs). This compound enables efficient conjugation to target proteins, allowing for selective degradation in cellular systems. Additionally, Bis-PEG6-NHS ester serves as a cleavable linker in the development of antibody-drug conjugates (ADCs), enhancing the therapeutic potential of these targeted delivery systems. Its versatility makes it an essential tool for research in drug development and targeted therapies.

Azido-PEG6-NHS ester is a cleavable 6-unit polyethylene glycol (PEG) linker designed for antibody-drug conjugate (ADC) synthesis. This compound serves as a versatile linker for PROTAC applications due to its ability to participate in click chemistry through the azide group. It can facilitate copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules and engage in strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN groups, making it an essential tool for chemical biology research.

Amino-PEG2-C2-acid is a cleavable polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This three-unit PEG-based linker facilitates effective drug delivery by linking cytotoxic agents to antibodies. Additionally, Amino-PEG2-C2-acid serves as a versatile linker for the development of proteolysis-targeting chimeras (PROTACs), enhancing their potential in targeted protein degradation applications.

Boc-Cystamine is a cleavable linker utilized in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the release of cytotoxic agents in targeted cells, enhancing the therapeutic efficacy of ADCs. Its application is critical in the development of targeted cancer therapies, where precision and controlled drug delivery are essential for minimizing off-target effects.

BCN-endo-PEG2-maleimide is a bifunctional ADC linker featuring two polyethylene glycol (PEG) units and a maleimide group. It acts as a bioconjugation reagent, facilitating stable linkages to azide-containing molecules through a copper-free click chemistry reaction, yielding stable triazoles. The maleimide moiety allows for selective conjugation to thiol groups, making it suitable for drug delivery applications. This compound is primarily utilized in the development of antibody-drug conjugates (ADCs) and other bioconjugation strategies.

PC Biotin-PEG3-azide is a cleavable three-unit PEG linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound features an azide functional group, enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules. Additionally, it participates in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN groups, making it a versatile tool for bioconjugation applications in chemical biology and therapeutic development.

Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a cleavable linker specifically designed for use in the development of antibody-drug conjugates (ADCs). This compound features an azide group that facilitates its application in click chemistry, allowing it to undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it is capable of participating in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions, making it versatile for conjugating with DBCO or BCN-containing compounds. It is an essential tool for enhancing the delivery and efficacy of therapeutic agents in targeted cancer therapies.

NH2-PEG6-Boc is a PEG-based linker primarily designed for the synthesis of PROTACs (Proteolysis Targeting Chimeras) and serves as a non-cleavable 6 unit PEG linker for antibody-drug conjugates (ADCs). It plays a critical role in optimizing the stability and efficacy of targeted therapeutics by facilitating the selective degradation of specific proteins. This compound is valuable in research applications focused on drug development and the exploration of targeted protein degradation mechanisms.

Azido-PEG3-SS-NHS is a cleavable polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound features an azide functional group, allowing it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) as well as strain-promoted alkyne-azide cycloaddition (SPAAC) reactions when paired with alkyne, DBCO, or BCN moieties. Its versatility in click chemistry enhances the development of targeted therapies by facilitating the precise attachment of cytotoxic agents to antibodies for efficient delivery and therapeutic action.

Aminooxy-PEG3-azide is a non-cleavable, three-unit PEG linker primarily used for the synthesis of antibody-drug conjugates (ADCs) and as a PEG-based linker in PROTAC development. This compound features an azide functionality that facilitates copper-catalyzed azide-alkyne cycloaddition reactions (CuAAc) with alkyne-containing molecules. Additionally, it can participate in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN-functionalized compounds, making it a versatile tool for chemical biology applications.

N3-TEMPO is an azide-containing click chemistry reagent that serves as a powerful tool for bioorthogonal reactions. It is capable of undergoing copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-bearing compounds, facilitating the conjugation of nucleic acids, lipids, and proteins. Additionally, N3-TEMPO can participate in ring strain-promoted azide-alkyne cycloaddition (SPAAC) with DBCO or BCN moieties. Its high yield, specificity, and operational simplicity make it valuable for various applications in chemical biology and bioconjugation research.

Boc-C14-COOH is a non-cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the conjugation of cytotoxic agents to antibodies, enhancing therapeutic efficacy while maintaining target specificity. Additionally, Boc-C14-COOH serves as an alkyl chain-based PROTAC linker, enabling the development of proteolysis-targeting chimeras for targeted protein degradation studies. Its applications extend to various fields, including cancer research and drug development.

Fmoc-Gly-Gly-OH is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the attachment of drugs to antibodies, enhancing targeted delivery and efficacy in tumor cells. Its use in research supports the development of novel therapeutic strategies in oncology, allowing for improved specificity and reduced systemic toxicity in cancer treatment approaches.

Bis-PEG13-NHS ester is a polyethylene glycol (PEG) based linker primarily utilized in the synthesis of PROTACs and antibody-drug conjugates (ADCs). This compound features a cleavable NHS ester that facilitates effective conjugation to target molecules, enhancing the delivery of therapeutic agents. Its application in constructing PROTACs allows for targeted protein degradation, making it a powerful tool in drug development and cancer research.

Fmoc-NH-PEG6-CH2COOH is a cleavable linker that targets PROTAC applications, facilitating the synthesis of antibody-drug conjugates (ADCs) and PROTACs. This PEG-based compound enhances the solubility and bioavailability of therapeutic agents. Its unique structure allows for selective cleavage, making it suitable for drug development and targeted protein degradation studies in various research settings.

Mal-amide-PEG8-Val-Ala-PAB-PNP is a cleavable linker specifically designed for antibody-drug conjugate (ADC) synthesis. This compound facilitates targeted drug delivery by allowing the selective release of therapeutic agents upon internalization in cancer cells. Its application in ADC development enhances therapeutic efficacy while minimizing off-target effects, making it a valuable tool for researchers in cancer treatment studies.

Azido-C6-OH is a cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This compound features an azide group and is suitable for click chemistry applications, as it can participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules. Additionally, Azido-C6-OH can engage in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with compounds that carry DBCO or BCN groups, making it a versatile tool for conjugation in chemical biology research.

Bis-PEG21-NHS ester is a polyethylene glycol (PEG) based linker with a primary mechanism as a cleavable ADC and PROTAC linker. This compound facilitates the synthesis of PROTACs and antibody-drug conjugates (ADCs) by providing a stable yet versatile connecting moiety. Its unique properties support targeted drug delivery and enhance the specificity of therapeutic applications in chemical biology research.

Boc-NH-PEG6-CH2CH2COOH is a cleavable linker primarily utilized in antibody-drug conjugates (ADCs). This PEG-based compound facilitates effective drug delivery by conjugating therapeutic agents to antibodies, enhancing target specificity and reducing off-target effects. Additionally, Boc-NH-PEG6-CH2CH2COOH can serve as a linker in the synthesis of PROTACs, contributing to the development of targeted protein degradation strategies in chemical research.

m-PEG8-Amine is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the targeted delivery of cytotoxic agents to cancer cells, enhancing therapeutic efficacy while minimizing systemic toxicity. Its application in ADC development supports advancements in targeted cancer therapies and drug delivery systems.

Boc-NH-PEG1-CH2CH2COOH is a cleavable ADC linker featuring a polyethylene glycol (PEG) moiety. This reagent facilitates the synthesis of antibody-drug conjugates (ADCs) by enabling the release of the drug payload upon cellular internalization. In addition, it can serve as a linker for alkyl/ether-based PROTACs, promoting targeted protein degradation in research applications.

Amino-PEG3-C2-acid is a cleavable polyethylene glycol (PEG) linker designed for the synthesis of antibody-drug conjugates (ADCs). This reagent enhances the therapeutic efficacy of ADCs by facilitating the selective release of cytotoxic agents within target cells. Additionally, Amino-PEG3-C2-acid serves as a PEG-based linker in the development of PROTACs, enabling targeted protein degradation for advanced research applications in drug discovery and development.

Biotin-PEG1-NH2 is a cleavable linker featuring a one-unit polyethylene glycol (PEG) structure, specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the conjugation of biotin to antibodies, enhancing stability and efficacy in targeted drug delivery. Its applications extend to cancer research where ADCs are utilized for selective targeting and therapy, providing a mechanism to improve therapeutic index and reduce off-target effects.

(R)-Azetidine-2-carboxylic acid is a non-cleavable linker specifically designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound effectively facilitates the stable attachment of therapeutic agents to antibodies, enhancing targeted delivery to cancer cells. Additionally, (R)-Azetidine-2-carboxylic acid serves as an alkyl chain-based PROTAC linker, providing versatility in the development of proteolysis-targeting chimera applications.

Fmoc-Ala-Ala-PAB is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This compound facilitates the efficient delivery of cytotoxic agents to target cells, enhancing therapeutic efficacy while minimizing off-target effects. Its properties make it a valuable tool in the development and optimization of ADCs for cancer research and treatment applications.

Azide-PEG3-Tos is a PEG-based PROTAC linker that facilitates the synthesis of proteolysis-targeting chimeras (PROTACs). This non-cleavable linker consists of a three-unit polyethylene glycol (PEG) structure, making it suitable for the development of antibody-drug conjugates (ADCs). Azide-PEG3-Tos acts as a click chemistry reagent, capable of undergoing copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules, as well as strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN groups. Its versatile reactivity and stability make it a valuable tool in chemical biology research and drug development.

Aminooxy-PEG2-azide is a PEG-based PROTAC linker that facilitates the synthesis of protein degraders. This non-cleavable 2-unit PEG linker is also utilized in the preparation of antibody-drug conjugates (ADCs). As a versatile click chemistry reagent, it features an azide group capable of undergoing copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules, as well as strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN groups. Its applications are essential in advancing targeted protein degradation and ADC development.

20-(tert-Butoxy)-20-oxoicosanoic acid is a non-cleavable linker utilized in the synthesis of antibody-drug conjugates (ADCs). This compound plays a crucial role in enhancing the stability and efficacy of ADCs by facilitating site-specific drug delivery. Additionally, it serves as an alkyl chain-based linker in the development of PROTACs, which are designed to induce targeted protein degradation. Its versatile applications make it a valuable tool in chemical biology and therapeutic research.

Bis-sulfone-PEG3-Azide is a cleavable linker designed for use in antibody-drug conjugate (ADC) synthesis. This compound features an azide functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAC) as well as strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules. Its versatility makes it a valuable tool in research applications focused on protein degradation and targeted delivery of therapeutic agents.

CL2A is a cleavable linker designed for antibody-drug conjugates (ADCs), incorporating PEG8 and a triazole structure within a PABC-peptide framework. This linker exhibits pH sensitivity, facilitating a bystander effect upon cleavage and forming a disulfide bond with cysteine residues on antibodies. CL2A is suitable for research applications focused on optimizing ADC formulations and enhancing therapeutic efficacy through targeted delivery mechanisms.

m-PEG8-NHS ester is a non-cleavable 8 unit polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs). Its primary mechanism involves forming stable amide bonds with antibody proteins via its N-hydroxysuccinimide (NHS) functionality. This reagent facilitates the conjugation of therapeutic agents to antibodies, enhancing the efficacy and specificity of targeted drug delivery in various cancer research applications.

Azetidin-3-ol hydrochloride is a non-cleavable linker for antibody-drug conjugates (ADCs) that facilitates the effective delivery of cytotoxic agents to targeted cells. This compound also serves as an alkyl chain-based PROTAC linker, enabling the synthesis of proteolysis-targeting chimeras for targeted protein degradation studies. Its applications extend to enhancing therapeutic efficacy in cancer research and other disease models.

Mal-PEG2-acid is a non-cleavable linker designed for use in antibody-drug conjugates (ADCs), facilitating the stable attachment of cytotoxic agents to antibodies. This reagent can be conjugated to Tubulysin and its derivatives, enabling targeted delivery of therapeutic compounds. Additionally, Mal-PEG2-acid serves as a linker in PROTAC synthesis, aiding in the development of innovative targeted protein degradation strategies.

Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine is a cleavable PEG linker designed for use in antibody-drug conjugates (ADCs) and PROTACs. Its unique structure facilitates the stable attachment of drugs to antibodies while preserving the ability to release the active compound upon internalization. This reagent is essential for researchers developing targeted therapies, enabling more efficient delivery and controlled release of therapeutic agents. Its versatility as both an ADC linker and PROTAC linker supports advancements in drug design and development workflows.

MC-Val-Ala-OH is a cleavable linker designed for use in antibody-drug conjugates (ADCs). It facilitates the precise release of therapeutic agents in a controlled manner upon internalization by target cells. This compound plays a crucial role in enhancing the efficacy of ADCs by ensuring targeted delivery and minimizing off-target effects, making it an essential reagent in cancer research and therapeutic development.